Topical treatment with STA-21, a STAT3 inhibitor, improved human psoriatic skin lesions as well as psoriasis-like dermatitis in K5.Stat3C transgenic mice, indicating a promising role of this agent in the treatment of psoriasis [68]. Here, STAT3 is linked to psoriasis.